DNACF stock forecast, quote, news & analysis

DNACF's RSI Oscillator is staying in overbought zone for 9 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 43 cases where DNACF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for DNACF moved below the 200-day moving average on July 23, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

DNACF broke above its upper Bollinger Band on July 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 28, 2025. You may want to consider a long position or call options on DNACF as a result. In of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

DNACF moved above its 50-day moving average on August 06, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for DNACF crossed bullishly above the 50-day moving average on August 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.068) is normal, around the industry mean (1.712). P/E Ratio (11.876) is within average values for comparable stocks, (40.640). DNACF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.493). Dividend Yield (0.013) settles around the average of (0.035) among similar stocks. P/S Ratio (1.752) is also within normal values, averaging (2.939).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DNACF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

DNACF paid dividends on June 21, 2021